RxSight, Inc. (RXST) Profit Margin
RxSight, Inc. (RXST) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -215.50% |
| 2022-12-31 | -136.22% |
| 2023-12-31 | -54.57% |
| 2024-12-31 | -19.62% |
| 2025-12-31 | -28.96% |
How RXST compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| FLGT | Fulgent Genetics Inc. | -18.75% |
| STIM | Neuronetics Inc. | -26.15% |
| AXSM | Axsome Therapeutics Inc. | -28.69% |
| PRGO | Perrigo Company plc | -33.51% |
| IONS | Ionis Pharmaceuticals Inc. | -40.41% |
These are five companies in the same sector as RXST with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get RxSight, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("RXST", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RXST | $6.36 | -1.85% | 0.31M |
| 3 | ||||
| 4 | ||||
| 5 |